Clinical Trial

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, prospective, real-world study. The study plans to include a total of 2000 patients who meet the inclusion and exclusion criteria, consisting of 1600 treatment-naive patients and 400 treatment-experienced patients. The effectiveness and safety of different treatment strategies will be evaluated in children aged 1-12 years with treatment-naive and treatment-experienced chronic hepatitis B (CHB) and chronic HBV infection.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-11.
Trial Details
NCT Number NCT06926647
Lead Sponsor Beijing 302 Hospital
Conditions HBV, Chronic Hepatitis b
Enrollment 2,000 participants
Start Date 2025-05-01
Primary Completion 2028-12-15 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-29